Literature DB >> 24726819

A systematic review of the ability of urine concentration to distinguish antipsychotic- from psychosis-induced hyponatremia.

Wanlop Atsariyasing1, Morris B Goldman2.   

Abstract

Life-threatening hyponatremia in psychotic patients is common and typically is attributable to either antipsychotic medication or to acute psychosis in those with the polydipsia-hyponatremia syndrome. The preferred treatment for one situation may worsen the hyponatremia if caused by the other situation. Hence it is critical to distinguish between these two possibilities. Case reports and series were identified through electronic databases. Fifty-four cases of hyponatremia without recognized causes in psychotic patients were divided into those with dilute (<plasma osmolality) or concentrated (>plasma osmolality) urine. The distribution of urine concentration and measures likely to be associated with psychotic illness and its treatment were compared in both groups. Naranjo׳s scale was utilized to determine the probability hyponatremia was drug-induced. Urine osmolality fit a bimodal distribution (intersection 219mOsm/kg) better than a unimodal distribution. 'Probable' drug-induced cases occurred 6.8 (95%CI=1.6-28.9) times more often in those with concentrated urine. Acute psychotic exacerbations occurred 4.5 (95%CI=0.4-54.1) times more often in those with dilute urine. These findings, as well as several other trends in the data, indicate that measures of urine concentration can help distinguish between antipsychotic-induced and psychosis-induced hyponatremia.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Reset osmostat; SIADH; Schizophrenia; Vasopressin; Water intoxication

Mesh:

Substances:

Year:  2014        PMID: 24726819      PMCID: PMC6195808          DOI: 10.1016/j.psychres.2014.03.021

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  33 in total

1.  The relationship between urine osmolality and specific gravity.

Authors:  Gentiana C Voinescu; Michael Shoemaker; Harold Moore; Ramesh Khanna; Karl D Nolph
Journal:  Am J Med Sci       Date:  2002-01       Impact factor: 2.378

2.  Syndrome of inappropriate secretion of antidiuretic hormone with exacerbated psychosis.

Authors:  S L Dubovsky; S Grabon; T Berl; R W Schrier
Journal:  Ann Intern Med       Date:  1973-10       Impact factor: 25.391

3.  Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia.

Authors:  M B Goldman; D J Luchins; G L Robertson
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

4.  Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients.

Authors:  Richard C Josiassen; Jessica L Curtis; Rita A Shaughnessy; Dawn M Filmyer; Alexander G Geboy; Nina Skuban; John Ouyang; Frank Czerwiec
Journal:  Clin Schizophr Relat Psychoses       Date:  2012-04

5.  Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.

Authors:  Cyndie K Mannesse; Eugène P van Puijenbroek; Paul A F Jansen; Rob J van Marum; Patrick C Souverein; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

6.  Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients.

Authors:  Morris B Goldman; Jennifer Gnerlich; Nadeem Hussain
Journal:  Neuropsychopharmacology       Date:  2006-12-13       Impact factor: 7.853

7.  Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome.

Authors:  C M Canuso; M B Goldman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

8.  Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study.

Authors:  Emily R Hawken; Jake M Crookall; Deirdre Reddick; Richard C Millson; Roumen Milev; Nicholas Delva
Journal:  Schizophr Res       Date:  2008-11-04       Impact factor: 4.939

9.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

10.  Manners of arginine vasopressin secretion in schizophrenic patients--with reference to the mechanism of water intoxication.

Authors:  T Kishimoto; M Hirai; H Ohsawa; M Terada; I Matsuoka; G Ikawa
Journal:  Jpn J Psychiatry Neurol       Date:  1989-06
View more
  6 in total

1.  Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study.

Authors:  Hang-Ju Yang; Wan-Ju Cheng
Journal:  Psychopharmacology (Berl)       Date:  2017-01-11       Impact factor: 4.530

2.  Hyponatremia in spinal cord injury patients: new insight into differentiating between the dilution and depletion forms.

Authors:  J Kriz; O Schuck; M Horackova
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

Review 3.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

Review 4.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

Review 5.  Pathophysiology of Drug-Induced Hyponatremia.

Authors:  Gheun-Ho Kim
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

6.  Drug-Related Hyponatremic Encephalopathy: Rapid Clinical Response Averts Life-Threatening Acute Cerebral Edema.

Authors:  Arthur J Siegel; Sophie S Forte; Nasir A Bhatti; Steven E Gelda
Journal:  Am J Case Rep       Date:  2016-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.